J-TEC develops autologous cell products under AMED contract

J-TEC, now a Fujifilm company, has started two projects under the Japan AMED mechanism (an NIH-type funding): the development of autologous epidermis including physician-led clinical trials for skin reconstruction, and the expansion of autologous mesenchymal stem cells for applications in ischemic diseases.

April 12, 2016

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny